Journals / Tüberküloz ve Toraks / 2000 / Cilt: 48 - Sayı: 2

The safety of bronchoalveolar lavage in asthmatic and interstitial lung disease patients

Bronkoalveoler lavajın astmalılar ve interstisyel akciğer hastalarında güvenilirliği

Pages
93–98
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is useful to follow up these patients closely after BAL.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: To evaluate the reliability of bronchoalveoler lavage (BAL) in the patients with asthma and with interstitial lung disease (ILD) determining its effects on pulmonary function tests (PFT) and arterial blood gases (ABG).
📊
Key Findings & Data:Method: PFT and ABG were determined before, within 30 minutes and 2 hours after BAL in 9 patients with asthma and 10 patients with ILD.
💡
Conclusion & Impact:It is useful to follow up these patients closely after BAL.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aims: To evaluate the reliability of bronchoalveoler lavage (BAL) in the patients with asthma and with interstitial lung disease (ILD) determining its effects on pulmonary function tests (PFT) and arterial blood gases (ABG). Method: PFT and ABG were determined before, within 30 minutes and 2 hours after BAL in 9 patients with asthma and 10 patients with ILD. All patients were given 2 L/min O2 with nasal cannulae during and after the procedure and asthmatics were given 200 µg inhaler b2 agonist before BAL. Results: FEV1 and FVC values significantly decreased in the asthmatics just after BAL (p 0.05). In ILD patients, FEV1 and FVC values decreased significantly just after and 2 hours after BAL (p 0.05). While arterial O2 saturation had not been changed in ILD, there was a decrease just after BAL with the improvement at the 2th hour in the asthmatics (p< 0.05). Conclusion: Asthmatics patients are more susceptible to the side effects of BAL than the patients with ILD. It is useful to follow up these patients closely after BAL.

Özet

Amaç: Bronkoalveoler lavaj (BAL)’ın astmalı ve interstisyel akciğer hastalıklı (İAH) hastalardaki solunum fonksiyon testleri (SFT) ve arter kan gazları (AKG) üzerine etkilerini saptayarak, bu yöntemin her iki hasta grubunda uygulanmasının güvenilirliğini saptamak. Metod: Çalışmamızda astmalı 9 hasta ile interstisyel akciğer hastalığı (İAH) olan 10 hastada işlemden hemen önce, işlemden sonra ilk yarım saatte ve işlemden sonra ikinci saatte solunum fonksiyon testleri ve arter kan gazları tespit edildi. Hastalara işlem sırasında ve işlemden sonra 1-2 L/dk oksijen nazal kanülle verildi ve astmalı hastalara işlemden önce kısa etkili b2 agonist 2 puff (200 µg) inhale ettirildi. Sonuçlar: Astmalılarda işlemden hemen sonra bakılan FEV1 ve FVC değeri işlemden öncekine göre anlamlı düşüş gösterdi (p 0.05). İAH olanlarda FEV1 ve FVC BAL’dan hemen sonra ve 2. saatte anlamlı düşüşler gösterdi (p 0.05). Oksijen saturasyonu İAH’li olgularda değişiklik göstermezken, astmalılarda işlemden hemen sonra görülen ve 2. saatte düzelen bir düşme gösterdi (p< 0.05). Sonuç: Astmalı olgular, BAL’ın solunum fonksiyonları ve kan gazları üzerindeki olumsuz etkilerine İAH’li olgulardan daha duyarlı olmaktadırlar. Bu hastaların BAL sonrası yakından takipleri faydalı olacaktır.

🔖

Cite This Article

ÖZDEMİR, N., ERGİNEL, S., KOLSUZ, M., MUTLU, S., ELBEK, O., YURDASİPER, A., HARMANCI, E. (2022). The safety of bronchoalveolar lavage in asthmatic and interstitial lung disease patients. Tüberküloz ve Toraks, Cilt: 48 - Sayı: 2, 93–98. https://ajindex.com/articles/619448

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Kelly C, Hendrick D, Watters H. The effect of bronchoalveoler lavage on bronchial responsiveness in patients with airflow obstruction, Chest 1988; 93: 325-8, 2. Chetta A, Foresi A, Bertorelli G, Pesci A, Olivieri D. Lung function and bronchiai responsiveness after brochoalveoler lavage and bronchial biopsy performed without premedication in stable astmatic subjects. Chest 1992; 101: 1563-8. 3. Lin C, Wu J, Huang W. Pulmonary function in normal subjects after bronchoalveoler lavage. Chest 1988; 93: 1049-53. 4. Djukanovic R, Wilson JW, Lai CKW, Hotgate S, Howarth PH. The safety aspects of fiberoptic bronchoscopy, bronc-hoalveoler lavage, and endobronchial biopsy in asthma. Am Rev Respir Dis 1991; 143; 772-7. 5. Belen J, Neuhaus A, Markowitz D, Rotman HH. Modification of the effect of fiberoptic bronchoscopy on pulmo-nary mechanics. Chest 1981; 79: 516-9. 6. Zavala DC, Godsey K, Bedell GN. The response to atropine sulfate given by aerosol and intramuscular routes to patients undergoing fiberoptic bronchoscopy. Chest 1981; 79:512-4. 7. Ancic P, Diaz P, Galleguillios F. Pulmonary function changes after bronchoalveoler lavage İn asthmatic patients. Br J Dis Chest 1984; 78: 261-3. 8. Rankin JA, Snyder PE, Schachter EN, Matthay RA. Bronchoalveoler lavage: its safety in subjects with mild astma. Chest 1984; 85: 723-8. 9. Nakhosteen JA. Bronchorfiberscopy in asthmatics: a method for minimizing risk of complications. Respiration 1978; 36: 112-6. 10. Van Vyve T, Cbanez P, Bousquet J, Lacoste JY, Michel FB, Godard P. Safety of bronchoalveoler lavage and bronchial biopsies in patients with asthma of variable severity. Am Rev Respir Dis 1992; 146: 116-21. 11. Tilles DS, Goldenheim PD, Ginns LC, Hales CA. Pulmonary function in normal subjects and patients with sar-coidosis after bronchoalveoler lavage. Chest 1986; 89: 244-8. 12. Strumpf IJ, Feld MK, Cornelius MJ, Keogh BA, Crystal RG. Safety of fiberoptic bronchoalveoler lavage in evaluation of interstitial lung disease. Chest 1981; 80: 268-71. 13. Hendy MS, Bateman JRM, Stableforth DE. The influence of transbronchial lung biopsy and bronchoalveolar lavage on arterial blood gas changes occuring in patients with diffuse interstitial lung disease. Br J Dis Chest 1984; 78: 363-8. 14. Banks DE, Bell DY, Davis GS. Bronchoalveoler lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis 1990; l41(Suppl): 169-202. 15. Peacock AJ, Benson-Mitchel R, Godfrey R.